ArticleArchives of medical science : AMS2019

Modulator role of infliximab and methotrexate through the transient receptor potential melastatin 2 (TRPM2) channel in neutrophils of patients with rheumatoid arthritis: a pilot study.

Atalay Dogru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.